Autor: |
Tony Kurian, Jason Peng, Courtney Regan Wagner, Fritzie S. Albarillo |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Journal of Clinical and Medical Case Reports. :1-5 |
DOI: |
10.31487/j.jcmcr.2020.02.06 |
Popis: |
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have demonstrated improved progression-free survival benefits and decreased treatment-related side effects, and therefore are now considered first-line of treatment of EGFR mutated, metastatic non-small cell lung carcinoma (NSCLC). Cryptococcal endocarditis is an extremely rare clinical entity with only seven reported cases in the literature. Prior cases were seen in patients with a history of rheumatic heart disease or prior valve replacement surgery. Little is known regarding the natural history and optimal management of Cryptococcal endocarditis, given the limited available data. We present a case of Cryptococcal endocarditis and meningitis in a patient with metastatic NSCLC receiving targeted therapy with an EGFR-TKI with no history of significant cardiac disease. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|